Literature DB >> 23013398

Immunological screening and characterization of highly specific monoclonal antibodies against 20 kDa hGH.

Hongwu Du1, Guangyu Chen, Shuang Wang, Shan Wang, Shaoxu Li, Chuanbao Li, Yiping Xun, Chunji He, Moutian Wu.   

Abstract

BACKGROUND: hGH has been widely abused as a doping agent in sports for many years. There are some important approaches for the detection of hGH doping, and the ratio of 22:20 kDa GH was considered one of the most suitable detection indicators of GH abuse. Currently, effective anti-GH antibodies and related reagents are needed to develop a detection method, in particular, highly specific anti-20 kDa hGH monoclonal antibodies are a prerequisite. Herein we constructed the expression vector of 20 kDa hGH and prepared the corresponding antibodies by the immunization of the recombinant human 20 kDa into mice. Positive clones that can specifically recognize 20 kDa hGH were screened and characterized by enzyme immunoassay, Dot-ELISA and surface plasmon resonance. In total, 14 specific monoclonal cell lines were screened out.
RESULTS: By a series of characterization, it was found that the 6C8, 44H3, 12G7 and 33Y19 clones were showing much higher specificity and affinity to 20 kDa hGH, and P3H9 could recognize both 20 and 22 kDa hGH isoforms. 6C8 and 44H3 matched well with P3H9 in the surface plasmon resonance testing. The 12G7 clone had the best surface properties with an association constant of 3.4 × 10(9) M(-1) and a dissociation constant of 2.95 × 10(10) M.
CONCLUSION: Highly specific monoclonal antibodies against 20 kDa hGH were generated, and also two paired antibodies (P3H9 and 6C8 or P3H9 and 44H3) were characterized, which can serve as the potential components for 22:20 kDa detection kit.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23013398     DOI: 10.4155/bio.12.188

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  8 in total

1.  Prohibitin as a novel autoantigen in rheumatoid arthritis.

Authors:  Li-Li Shi; Peng Chen; Yi-Ping Xun; Wei-Kang Yang; Chun-He Yang; Guang-Yu Chen; Hong-Wu Du
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

2.  Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease.

Authors:  Peng Chen; Hai Yan; Yaping Tian; Yiping Xun; Lili Shi; Ran Bao; Huai Zhang; Guangyu Chen; Chunhe Yang; Shutao Sun; Yajie Wang; Li Liu; Yabin Zhou; Chunyan Zhang; Xiaoxu Wang; Yongqiang Wen; Yongzhong Bian; Hongwu Du
Journal:  Sci Rep       Date:  2015-02-02       Impact factor: 4.379

3.  Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays.

Authors:  Stephen Vance; Effat Zeidan; Vincent C Henrich; Marinella G Sandros
Journal:  J Vis Exp       Date:  2016-01-07       Impact factor: 1.355

4.  Circulation autoantibody against Lamin A/C in patients with Sjögren's syndrome.

Authors:  Wen Zhang; Chunyan Zhang; Peng Chen; Chunhe Yang; Xianfeng Gan; Muhammad Hussain; Yiping Xun; Yaping Tian; Hongwu Du
Journal:  Oncotarget       Date:  2016-12-06

5.  Circulation autoantibodies against C-terminus of NuMA in patients with Behçet's disease.

Authors:  Muhammad Hussain; Fuxin Ma; Peng Chen; Yaping Tian; Hongwu DU
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085

6.  Electron Transfer Flavoprotein Subunit Beta Is a Candidate Endothelial Cell Autoantigen in Behçet's Disease.

Authors:  Peng Chen; Weikang Yang; Yaping Tian; Shutao Sun; Guangyu Chen; ChunYan Zhang; Fuxin Ma; Yiping Xun; Lili Shi; Chunhe Yang; Lanqing Zhao; Yabin Zhou; Hongwu Du
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

7.  Expression correlates between Annexin A1 and A2 autoantibodies in patients with Behçet's disease.

Authors:  Muhammad Hussain; Peng Chen; Guang Mei; Yongzhe Li; Hongwu Du
Journal:  Biosci Rep       Date:  2018-01-19       Impact factor: 3.840

8.  Moesin expression is correlated with its involvement in patients with Behcet's disease.

Authors:  Muhammad Hussain; Peng Chen; Yixuan Zhang; Yaping Tian; Hongwu Du
Journal:  Arch Med Sci       Date:  2020-02-12       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.